Placement of prophylactic pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: A meta-analysis

Table 3 Incidence of hyperamylasemia

Ref.	Year	Hyperamylasemia
		Stent (n)	Control (n)	P value
Kawaguchi et al[16]	2012	18	23	0.862
Lee et al[17]	2012	8	6	0.538
Sofuni et al[14]	2011	86	68	0.200
Ito et al[19]	2010	21	26	NA
Sofuni et al[15]	2007	31	34	0.996
Tsuchiya et al[23]	2007	11	16	NS

NA: Not available; NS : Not significant.